Showing 13 to 18 of 18 results


Irish Politician Richard Boyd Barrett Diagnosed with Throat Cancer
Irish politician Richard Boyd Barrett, 58, announced a throat cancer diagnosis, requiring 3-4 months of treatment; he'll temporarily step back from politics but plans to return. The cancer, linked to HPV, was detected early, increasing the chances of recovery.
Irish Politician Richard Boyd Barrett Diagnosed with Throat Cancer
Irish politician Richard Boyd Barrett, 58, announced a throat cancer diagnosis, requiring 3-4 months of treatment; he'll temporarily step back from politics but plans to return. The cancer, linked to HPV, was detected early, increasing the chances of recovery.
Progress
4% Bias Score


Low Cervical Cancer Screening in Spain Highlights HPV Risk
A low participation rate in Spain's cervical cancer screening program, using HPV testing since 2019, raises concerns about increased cancer cases, given the high global prevalence of HPV and its link to various cancers. A new study reveals 7.4% oral HPV prevalence in Europe and the US, with higher r...
Low Cervical Cancer Screening in Spain Highlights HPV Risk
A low participation rate in Spain's cervical cancer screening program, using HPV testing since 2019, raises concerns about increased cancer cases, given the high global prevalence of HPV and its link to various cancers. A new study reveals 7.4% oral HPV prevalence in Europe and the US, with higher r...
Progress
20% Bias Score


Sweden Aims to Eliminate HPV-Related Cancers by 2027
Sweden is launching a national project to eliminate HPV-related cancers by 2027 through widespread vaccination (90% of girls, 85% of boys), a catch-up vaccination program for women born 1994-1999, and mass screening starting in 2025; the project costs €350,000 this year.
Sweden Aims to Eliminate HPV-Related Cancers by 2027
Sweden is launching a national project to eliminate HPV-related cancers by 2027 through widespread vaccination (90% of girls, 85% of boys), a catch-up vaccination program for women born 1994-1999, and mass screening starting in 2025; the project costs €350,000 this year.
Progress
44% Bias Score

HPV: Vaccines, Screenings, and the Fight for Cervical Cancer Elimination
Human Papillomavirus (HPV) infects over 80% globally; while effective vaccines and screenings exist, unequal access remains a challenge; Spain's vaccination coverage exceeds 92%, and the country is shifting to population-based screenings to improve equitable access and reduce cervical cancer inciden...

HPV: Vaccines, Screenings, and the Fight for Cervical Cancer Elimination
Human Papillomavirus (HPV) infects over 80% globally; while effective vaccines and screenings exist, unequal access remains a challenge; Spain's vaccination coverage exceeds 92%, and the country is shifting to population-based screenings to improve equitable access and reduce cervical cancer inciden...
Progress
12% Bias Score

Understanding Menstrual Cycles Crucial for Early Cervical Cancer Detection
A UK pharmacist highlights the importance of understanding menstrual cycles for early cervical cancer detection, citing a daily death toll of two women in Britain from this disease while emphasizing a 95 percent survival rate with early diagnosis.

Understanding Menstrual Cycles Crucial for Early Cervical Cancer Detection
A UK pharmacist highlights the importance of understanding menstrual cycles for early cervical cancer detection, citing a daily death toll of two women in Britain from this disease while emphasizing a 95 percent survival rate with early diagnosis.
Progress
28% Bias Score

USPSTF Recommends HPV Testing as Primary Cervical Cancer Screening
The US Preventive Services Task Force (USPSTF) preliminarily recommends high-risk HPV testing every 5 years, including self-collected samples, as the preferred cervical cancer screening strategy for women aged 30-65, prioritizing it over Pap smears due to its superior effectiveness and potential for...

USPSTF Recommends HPV Testing as Primary Cervical Cancer Screening
The US Preventive Services Task Force (USPSTF) preliminarily recommends high-risk HPV testing every 5 years, including self-collected samples, as the preferred cervical cancer screening strategy for women aged 30-65, prioritizing it over Pap smears due to its superior effectiveness and potential for...
Progress
48% Bias Score
Showing 13 to 18 of 18 results